Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
19.99
+0.34 (1.73%)
At close: Nov 4, 2026, 4:00 PM EST
19.90
-0.09 (-0.45%)
After-hours: Nov 4, 2026, 7:30 PM EST
Faeth Therapeutics Employees
Faeth Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 14 or 93.33% compared to the previous year. That makes Faeth Therapeutics the 37,174th largest employer in the world and 5,203rd in the United States.
Employees
29
Change (1Y)
14
Growth (1Y)
93.33%
Revenue / Employee
n/a
Profits / Employee
-$7,288,207
Market Cap
516.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 14 | 93.33% | 29 | 0 |
| Dec 31, 2024 | 15 | -13 | -46.43% | 14 | 1 |
| Dec 31, 2023 | 28 | 0 | - | 27 | 1 |
| Dec 31, 2022 | 28 | -28 | -50.00% | 28 | 0 |
| Dec 31, 2021 | 56 | 24 | 75.00% | 56 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| Phathom Pharmaceuticals | 371 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Surrozen | 44 |
| DiaMedica Therapeutics | 35 |
| Ovid Therapeutics | 23 |
FTH News
- 17 hours ago - Faeth Therapeutics price target lowered to $69 from $70 at Guggenheim - TheFly
- 1 day ago - Faeth Therapeutics reports Q3 EPS (79c), consensus (71c) - TheFly
- 1 day ago - Faeth Therapeutics Reports Third Quarter 2026 Financial Results and Operational Updates - Business Wire
- 1 day ago - Faeth Therapeutics Quarterly report: Q3 2026 - Filings
- 1 day ago - Faeth Therapeutics Earnings release: Q3 2026 - Filings
- 8 days ago - Faeth Therapeutics appoints Adam Schayowitz to board of directors - TheFly
- 8 days ago - Faeth Appoints Adam Schayowitz, Ph.D., MBA, Head of Research and Development at Zymeworks, to Board of Directors - Business Wire
- 12 days ago - Faeth Therapeutics presents updated preclinical data on PIKTOR at ESMO - TheFly